Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
1.400
+0.130 (10.24%)
At close: Sep 8, 2025, 4:00 PM
1.400
0.00 (0.00%)
Pre-market: Sep 9, 2025, 4:05 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '10 2013 - 2019
Vision Performance and Health
10.99M
Log In
Log In
Log In
Log In
Upgrade
Vision Performance and Health Growth
-42.30%
Log In
Log In
Log In
Log In
Upgrade
Innovative Treatments
-
Log In
Log In
Log In
Log In
Upgrade
Innovative Treatments Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '10 2013 - 2019
United States
10.99M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-42.30%
Log In
Log In
Log In
Log In
Upgrade